SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000920465-15-000055
Filing Date
2015-08-06
Accepted
2015-08-06 16:42:34
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ljpc-2015630x10q.htm 10-Q 461128
2 EXHIBIT 31.1 ljpc-2015630xexhibit311.htm EX-31.1 14000
3 EXHIBIT 31.2 ljpc-2015630xexhibit312.htm EX-31.2 14639
4 EXHIBIT 32.1 ljpc-2015630xexhibit321.htm EX-32.1 11722
  Complete submission text file 0000920465-15-000055.txt   2922068

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ljpc-20150630.xml EX-101.INS 481882
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20150630.xsd EX-101.SCH 20872
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20150630_cal.xml EX-101.CAL 24531
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20150630_def.xml EX-101.DEF 133973
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20150630_lab.xml EX-101.LAB 368800
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20150630_pre.xml EX-101.PRE 204141
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36282 | Film No.: 151033710
SIC: 2836 Biological Products, (No Diagnostic Substances)